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Abstract: Biotechnology and nanotechnology are the key technologies of the twenty-first 
century, having enormous potential for innovation and growth. The academic and industrial 
goals for these technologies are the development of nanoscale biomolecular substances and 
analytical instruments for investigating cell biology at the cellular and molecular levels. 
Developments in nanotechnology will provide opportunities for cosmetic dermatology to 
develop new biocompatible and biodegradable therapeutics, delivery systems and more active 
compounds. Cosmetics have the primary function of keeping up a good appearance, changing 
the appearance, or correcting body odors, while maintaining the skin and its surroundings in 
good conditions. Thus cosmetic dermatology, recognizing the new realities of skin care products, 
has to emphasize the functional aspects of cosmetics through an understanding of their efficacy 
and safety in promoting good health. Nanoscience may help the scientific community to find 
more innovative and efficacious cosmetics. Understanding the physical model of the cell as a 
machine is essential to understand how all the cell components work together to accomplish 
a task. The efficacy and safety of new nanomaterials has to be deeply studied by ex vivo tests 
and innovative laboratory techniques. New delivery systems and natural nanocompounds, such 
as chitin nanofibrils for wound healing, are being used in cosmetic dermatology with good 
results, as are nanostructured TiO2 and ZnO sunscreens. The challenge is open.
Keywords: nanotechnology, nanobiotechnology, delivery systems, chitin nanofibrils, 
TiO2, ZnO
The significance of nanotechnology  
and nanobiotechnology
Nanotechnology is a relatively young discipline. Today nanotechnology is not only 
essential for marketing-oriented chemical companies, but also a tool for developing 
science-based solutions for innovative therapeutics and cosmetics, enhancing 
well-being and addressing anti-aging issues.1 Nanotechnology is defined as the 
study of matter on an atomic or molecular scale. Generally, nanotechnology deals 
with structures the exact size and shape of which must be measured on a nanometric 
scale.2–4 A nanometer (nm) is one billionth of a meter (ie, 10–9) and typical atoms are 
about one third of a nanometer. In comparison the medial thickness of a human hair 
is about 10000 nm and an influenza virus has a diameter of 100 nm (see Figure 1). 
Nanobiotechnology, the interface between nanotechnology and biotechnology, is the 
branch of nanotechnology that deals with its biological and biochemical applications 
or uses.Clinical, Cosmetic and Investigational Dermatology 2010:3 
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Nanotechnology is thus the set of methods and techniques 
for processing matter on atomic and molecular scales to create 
products with both special and improved chemico–physico 
features compared to conventional products.5 Therefore, the 
goal of nanobiotechnology is the development of nanoscale 
biomolecular components and analytical instruments for 
the investigation of cell biology at both the cellular and 
molecular levels.
The expectations
The potential uses and benefits together with the expectations 
of nanosciences are enormous. Accordingly, the European 
Commission (EU) supports the new nanotechnologies 
through its seventh framework program (Figure 2). Thus, 
the use of nanomaterials in cosmetic dermatology is the 
subject of intense debate in the EU, and efforts to establish 
fundamental rules for their use and risk assessment are 
ongoing throughout universities, government laboratories 
and industry. Investment of public funds in basic 
nanotechnology research has increased, which has, in turn, 
heightened the interest of private industry in developing 
patented products.6 The nanoscale production of a raw mate-
rial may not only reduce costs, but also enhance its properties. 
In the biomedical and cosmetic fields nanotechnology has 
enormous potential, and nanobiotechnological methods are 
already being used in both medicine and the pharmaceuti-
cal industry.
For all these reasons, the International Organization for 
Standardization (ISO)7 is developing uniform standards 
for nanotechnology and supporting innovation, research 
and development, including appropriate risk assessment 
research, in this innovative field.
However, to obtain nanoscale materials a combination 
of physical micro-nanoelectronic, chemical and biological 
technologies are necessary. Currently, the three main areas 
of development include the following:8
nanomaterials: building specialized structures whose 
dimensions are controlled on a nanoscale;
nanobiotechnology: the manipulation of living systems 
using nanoscale engineering;
nanoelectronics: the development of microelectronics for 
devices such as radio frequency identification.
Nanomaterials in cosmetic 
dermatology
Nanomaterials and nanobiotechnology have the potential to 
radically change the way cosmetics and drugs deliver their 
benefits. Specifically, nanoparticles are being developed 
to encapsulate a wide range of ingredients benefical to 
the skin.
To obtain nanoparticles, two principles approaches 
are used:
a)    the bottom-up method in which nanoparticles are 
assembled from the molecular dimension
b)    the top-down approach that reduces larger particles 
by the use of chemico–physico methods. In cosmetics 
the top-down approach is more commonly used to 
produce different kind of structures. Examples of such 
structures include nanosomes, cubosomes, niosomes, 
and liposomes.
Figure 1 The nanometer dimension.
Fullerene molecule
Nanotube
Quantum dots Titanium dioxide
1 A 1 nm 10 nm 100 nm 10 µm 1 µm 100
Atom Chitin Nanofibrils Bacterium Human Cell Human Hair
Source: Mavi Sud 2009
Dendrimers
°Clinical, Cosmetic and Investigational Dermatology 2010:3 
Nanotechnology in cosmetic dermatology Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
These labile particles with diameters from 50 to 5000 nm 
are used to produce micro- or nanoemulsions capable of 
carrying and protecting active compounds from oxidation, 
and also improve their penetration through the skin layers9 
(Figure 3).
One of the major factors that determines the ability of 
substances to penetrate the skin is the size of the molecule. 
According with Johann Wiechers, the role of a delivery 
system is to ensure that the right concentration of the right 
chemical is reaching the right site in the body for the correct 
period of time.10 However, the efficiency of an active com-
pound depends largely on its bioavailability – it is vital that 
it reaches the site of action and be released for a prolonged 
period of time.
To this end, recent extensive research has developed 
different nanotechnology oriented, controlled delivery 
Financing 2007 to 2013
Budget increase to approximately 3.5 Billion Euros
Increase in real terms is about 40%
Nanosciences and Nanotechnologies,
Materials and
New Production Technologies
700
600
500
400
300
200
100
0
2OO9 2OO7 2OO8 2O12 2O11 2O1O
Milano 16 November 2006 Source: O. Demuth SEVENTH FRAMEWORK
PROGRAMME 
Community Research
Figure 2 Provisional increase of nanotechnology.
Figure 3 Types of delivery systems. reproduced courtesy of Pat Meyer, Lipo Chemicals.
Lipocapsules®
(Gelatin)
Lipocapsules®
(PMU / MMM)
Lipospheres® LipobeadTM LipoparticleTM
Dry particles
30% Maximum
5–500
Internal phase Internal phase
INTERNAL 
PHASE
Internal phase
Form
Size (micron)
Soft/Pliable Hard/Brittle
Soft and pliable
spheres
Water swellable
dry bead
15–3000
60–97% 50–80% 5% Maximum 25% Maximum
5–100 500–4000 700 & 1500
Membrane (Shell)
Polymer shell
Appearance
Structure
Internal 
phase
Pores
matrix membrane Matrix membrane
Source: Mayer P. (2008) Microencapsulation TechnologiesClinical, Cosmetic and Investigational Dermatology 2010:3 
Morganti Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
systems, from the simplest to the most sophisticated10 
(Figure 4).
Thus nanovesicles, as a skin delivery system, and solid 
lipid nanoparticles (SLN) or nanostructured lipid carriers 
(NLC), have been developed for cosmetic and pharmaceutical 
applications.11
Vesicles are hollow colloidal particles, consisting of 
amphiphilic molecules. Because of their amphiphilic prop-
erties, these molecules can, in the presence of water, form 
unilamellar or multilamellar vesicles. Both water-soluble 
and water-insoluble compounds can be entrapped in such 
vesicles and a wide variety of lipids and surfactants can be 
used to prepare them.
These vesicles might act: (a) as carriers to deliver entrapped 
molecules into or across the skin; (b) as penetration enhancers 
to modify the intercellular lipid lamellae; (c) as a depot for 
sustained release of active compounds; (d) as a site-limiting 
membrane barrier for a controlled transepidermal or trans-
dermal delivery system.
In contrast to a vesicles-based delivery system, SLN and 
NLC have the great advantage of high stability. Moreover, 
these lipid carriers create a nanolayer lipid film on top of the 
skin, thereby avoiding water evaporation and thus increasing 
skin hydration.
Furthermore, the small size of all the nanostructured 
compounds ensures a closer contact with the stratum 
corneum, thus increasing the amount of incorporated active 
ingredients reaching the site of action. Wetting, spreading 
and penetration also may be enhanced as a result of the low 
surface tension of the whole system and the low interfacial 
tension of the oil/water (O/W) nanodroplets.
However, all the nanoparticles obtained from different 
emulsions have to be considered labile forms, because of the 
total disintegration of their components after application to 
the skin surface. Moreover, their mean dimension in cosmetic 
emulsions is about 100 nm.
Another group of nanoparticles widely used in cosmetic 
dermatology and totally insoluble both in water and oil 
includes the inorganic physical UV filters titanium dioxide 
(TiO2) and zinc oxide (ZnO), considered sunscreen in 
the US and Japan, and in Germany only among the EU 
countries. These two substances are used in particles of 
60 to 200 nm to obtain a transparent emulsion, thus increas-
ing cosmetic compliance (Figure 5). Of note is that the 
miniaturization of these minerals increases not only their 
transparency, but also their filtering capacity,12 because of 
their higher reflective index.
Therefore, these minerals may be considered as 
broad-spectrum UV blockers when used in micronized 
form, becoming invisible after application to the skin13 
(Figure 6). Additionally, the surface of these nanofilters may 
be coated with a neutral material such as silica, polysiloxane 
compounds, glass, or aluminium oxide, to improve their 
dispersion state, photostability and efficacy, eliminating 
direct contact with the skin (Figure 7) and increasing their 
margin of safety.14 As TiO2 is not only a UVA filter, but also 
an extremely efficient UVB filter, it shows by far the highest 
versatility of any sunscreen product.15
Physical
Associations
Encapsulation
(No release)
Encapsulation
with Release
(”one shot”)
Controlled/
Sustained
Release
Sequential
Release
Combination
of ingredients
Protection of
actives in pre-
and post
applications
Protection of
actives prior use.
Release at
application
Delivery at the
substrate at the
right time
Multiple actives
that need to be
release at
different times
Carriers
Emulsions
Gels
Synergy
Ingredient
coating
Capsules
µcapsules
Polymeric
Systems Polymeric
Systems
Multiple phase
polymeric or
vesicular
systems
Molecular
Systems Molecular
Systems
Vesicular
Systems
(Liposomes)
3D patch
Source: Mayer P. (2008) Microencapsulation Technologies
•
•
•
•
• •
•
•
•
•
•
•
•
•
Figure 4 Delivery systems: from the simplest to the most complicated. reproduced courtesy of Pat Meyer, Lipo Chemicals.Clinical, Cosmetic and Investigational Dermatology 2010:3 
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Another important group of insoluble nanoparticles 
used in cosmetics are microcapsules. These are small 
particles containing an active agent or core material 
surrounded by a coating layer or shell. Their diameter may 
vary from 1 to 1000 µm; capsules smaller than 1 µm are 
called nanocapsules and capsules larger than 1000 µm are 
called macrocapsules.16–18 Microcapsules may help to solve 
problems in cosmetic dermatology such as incompatibility 
of different ingredients, and protection of substances liable 
to oxidation or affected by atmospheric moisture.
The general outcome of EU discussions on the safety of 
nanomaterials in cosmetic dermatology indicates that some 
risks are inevitable, although conventional toxicological 
methodologies are not adequate to assess their safety. 
At present, these risks remain hypothetical because these 
discussion statements are not supported by documented 
research results.19–23 Recently the EU Parliament has passed 
a resolution on the regulatory aspect of nanomaterials,24 
considering them necessary for EU citizens, if made and 
distributed in a responsible manner.
The EU Parliament has stressed the need for legisla-
tion that includes a more comprehensive science-based 
definition of nanomaterials, together with a clear assignment 
of liability to producers and employers arising from the use 
of nanomaterials, through all routes of exposure (such as 
inhalation and the skin).
Recent studies on the safety of nanomaterials for human 
health have led, for example, to false-positive or false-
negative results and conclusions because of shortcomings 
in applied protocols (Table 1).25–36 Thus the Commission on 
Nanoscience has provided a “Code of Conduct for all indi-
viduals and civil society organizations involved or interested 
in nanosciences and nanotechnologies (N&N) research”.37 
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Figure  The level of transparency in consumer panel tests depending on the dimension of ZnO/TiO2 particles. Courtesy   Antaria Limited.
Figure  A face covered with standard ZnO (on the right, ie, subject’s left side) or 
nano-size ZnO (on the left, ie, subject’s right side). reproduced courtesy of Geoff 
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Table 1 A review of the results of   TiO2 and ZnO percutaneous absorption studies
Test material Particle size Skin model/technique Results Reference
TiO2 and ZnO  
(no information on coating)
TiO2: 50 to 100 nm  
ZnO: 20 to 200 nm
Human skin, in vitro Penetration limited to upper layers 
of stratum corneum
27
TiO2 AI2O3/stearic acid 
coated
150 nm to 170 nm Human subjects (biopsy) Particles on and in the upper layers 
of stratum corneum.   About 1% of particles 
in the ostium of the follicle. No penetration 
into living skin
28
various TiO2 anatase and 
rutile, coated and uncoated 
materials
14 nm to 200 nm Pig and human skin  
in vitro, human subjects  
(skin stripping or biopsy)
No penetration beyond the stratum 
corneum in any study
29
TiO2 (SiO2 Al2O3 + SiO2 
coated)
10 nm to 100 nm Human skin, in vitro Penetration of particles into the upper 
layers of stratum corneum. No penetration 
into living skin
30
TiO2 (SiO2 - Al2O3 Al2O3/
SiO2 coated)
10 nm to 100 nm Human subjects (biopsy) Particles on or in the outmost surface of 
the stratum corneum. No penetration into 
living skin
31
TiO2 (no coating) 20 nm Human skin, in vitro Penetration in restricted to the topmost 
3–5 corneocyte layers in the stratum 
corneum disjunctum. No penetration into 
living skin
32
TiO2 in various 
formulations  
(no information on coating)
Needles: 45 to  
150 nm × 17 to 35
Pig skin, in vitro Particles on/in the stratum corneum; 
minimal penetration into stratum 
granulosum. No penetration into living skin
33
ZnO 15 nm to 30 nm Human skin, in vitro Less than 0.03% of applied Zn recovered in 
the receptor solution, no particles detected 
in epidermis or dermis
34
TiO2
 (SiO2 or dimethicon 
coated) and ZnO 
(uncoated)
TiO2: 30 to 60 nm 
ZnO: 160 nm
Pig skin, in vitro No penetration beyond stratum corneum. 
receptor solution recoveries of 0.8%–1.4% 
of applied dose
35
TiO2 in a sunscreen 
formulation, silicone coated
20 nm Human skin in vitro 
and human subjects, 
skin stripping, TeM, 
backscattering 
spectometry
Penetration limited to upper layers 
of stratum corneum. No penetration 
in skin furrows or follicular opening 
may be mistaken for penetration in the 
epidermal compartment
36
This Code of Conduct aims to promote integrated, safe and 
responsible nanoscience and nanotechnology research in 
Europe for the benefit of society as a whole. Moreover the 
code must be considered complementary to existing regula-
tions. Thus far nanobiotechnology seems to pose no special 
risks for medicine and pharmacology.38,39
However, nanotechnology is a very broad term, and most 
fears about human health arise as a result of the specific 
properties of nanomaterials and nanoparticles, whether 
natural or man-made. In fact, natural nanoparticles do occur 
in the environment, for example in waste matter, some of 
which are are not materials engineered by scientists.39,40
One type of natural nanoparticle, chitin nanofibrils, are 
currently used by our research group as an active compound  Figure  Sunscreen covered by glass at level of horny layer. Courtesy Merck KGaA.Clinical, Cosmetic and Investigational Dermatology 2010:3 11
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in cosmetic dermatology. Research results obtained to date 
suggest this particle poses no risks to consumers but offers 
numerous benefits.41,42
Chitin nanofibril
A chitin nanofibril is a nanocrystal of a natural polysac-
charide obtained from the crustacean exoskeleton after 
elimination of the carbonate and protein portions. Having a 
backbone like hyaluronic acid, chitin nanofibrils are easily 
metabolized by the body’s endogenous enzymes and thus is 
used in cosmetic dermatology and biotextiles. The crystal is 
so named because its average size is 240 × 7 × 5 nm (nano), 
and because it is shaped like a thin needle (fibril). Moreover, 
because it occurs naturally and is considered a safe raw mate-
rial, it is safe to use. As it is easily metabolized by enzymes, 
it is both bio- and eco-compatible. As the nanofibril has 
an average size one-quarter that of a bacterium, 1 g of the 
product covers a surface area of 400 m2.43,44 Many studies 
have shown that chitin nanofibrils can activate the prolif-
eration of keratinocytes as well as fibroblasts, regulating 
not only collagen synthesis but also cytokine secretion and 
macrophage activity.45,46
Our group has obtained interesting results showing 
how chitin nanofibrils can ameliorate not only the appearance 
of photoaged skin47–51 but also promote wound healing by 
reducing hypertrophic scar formation52,53 (Figure 8). In vitro 
studies have shown how chitin nanofibrils can increase the 
reproduction of fibroblasts with a subsequent increase in 
collagen synthesis and in adenosine triphosphate production. 
In an in vivo double-blind study, skin hydration and superficial 
skin lipids were improved, with a simultaneous reduction in 
lipid peroxides and transepidermal water loss.49–51 By using 
different types of emulsions, chitin nanofibrils have an inter-
esting wound healing activity.52,53 Healthy biotextiles have 
also been produced.54
Research efforts in cosmetic dermatology are currently 
aimed at developing new environmentally friendly nanosized 
chemicals and new nanoparticulate systems for the skin. 
Therefore, during recent years several delivery systems have 
been developed (visible beads, microcapsules, nanocapsules 
and liposomes, or lipid nanoparticles, SLN) for the cosmetic 
and dermatological industry, and successively introduced into 
many marketed products. Many different active components 
can be encapsulated in these delivery systems, such as vitamins 
fragrances, botanical extracts, and drugs, which have a wide 
range of cosmetic or dermatological properties.
Some of these delivery systems, such as SLN, 
are innovative drug carrier systems first designed for 
intravenous administration and more recently investigated 
for peroral and transdermal applications in cosmetic 
dermatology. Thus, chemically labile agents should be pro-
tected from degradation and the release profile modulated. 
The much higher surface-to-mass ratio of nanomaterials 
should increase the efficacy of many active compounds.
In conclusion it is necessary to understand better the 
potential of these new technologies, so that the potential 
negative effects of their chemistry on human health and the 
environment may be minimized or avoided.
Nanoscience and nanoengineering could significantly 
improve our understanding of nanoscale processes at the 
molecular level that occur in the environment. Consequently 
it should be possible to develop new green technologies 
that minimize the production of undesirable byproducts 
released into the environment, into waste sites and streams for 
example.55 Nevertheless, to speed up the development of both 
nanotechnology and nanobiotechnology, multidisciplinary 
teams of highly trained people with backgrounds in 
biology, medicine, applied and computational mathematics, 
physics, chemistry, and electrical, chemical and mechanical 
engineering will be needed. Despite the current international 
Figure  Wound healing activity of chitin nanofibrils.
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financial crisis, nanotechnology and innovative cosmetic 
dermatology, may have the potential to help reinvigorate a 
nation’s economy (Figure 9). However, apart from helping 
to overcome some new challenges in molecular imaging 
techniques, quantitative analytical tools, physical models of 
the cell as a machine, better in vivo tests and better drug/
cosmetic delivery systems, nanotechnology could play an 
important role in the sustainability of not only cosmetic 
dermatology but also of agriculture, water filtering, energy 
materials, and a clean environment.
In conclusion, the most complex and highly functional 
nanoscale systems have been invented by nature. We have to 
find ways of how to best use them for ameliorating our well-
being and the environment. Thus, nano-products should be 
designed and sold in a way that fully respects the health of 
consumers and the environment. Both nanotechnology and 
biotechnology have the potential to revolutionize both our 
industries and way of life. They represent the key technologies 
of the twenty-first century, offering excellent opportunities 
for both research and business.
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